Refractory myocardial ischemic syndromes: patients' characterization and treatment goals

Area of Science:

• Cardiology
• Regenerative Medicine
• Medical Imaging

Background:

• Experimental therapies like gene transfer and cell transplantation aim to improve perfusion and contractility in ischemic heart disease.
• Current patient selection criteria for these advanced therapies are inconsistent, hindering research and clinical application.

Purpose of the Study:

• To propose standardized definitions for identifying "no option" ischemic cardiac patients.
• To establish clear endpoints for evaluating the efficacy of myocardial revascularization strategies.

Main Methods:

• Defining patient characteristics: lack of revascularization options, angina symptoms, limited exercise capacity, perfusion defects, and identifiable target regions.
• Establishing treatment endpoints: improved exercise tolerance, reduced perfusion defects, symptom relief, enhanced myocardial stress response, better quality of life, and improved collateral-dependent perfusion.

Main Results:

• Proposed standardized criteria for patient selection in "no option" ischemic heart disease.
• Defined favorable clinical effect endpoints to assess treatment efficacy.

Conclusions:

• A systematic approach to patient evaluation and treatment endpoint assessment is crucial for "no option" ischemic cardiac patients.
• Standardized definitions will enable accurate efficacy assessment and facilitate comparison across different myocardial revascularization trials.